Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFoxtons Regulatory News (FOXT)

Share Price Information for Foxtons (FOXT)

Share Price is delayed by 15 minutes
Get Live Data
45.10    -0.70 (-1.53%)
Bid:
45.10
Ask:
46.35
Spread: 1.25 (2.772%)
Market Cap: £133.36m
FOXT Live PriceLast checked at - London Stock Exchange

Intraday Foxtons Share Chart

Directorate Change

20 May 2019 08:00

RNS Number : 4705Z
Foxtons Group PLC
20 May 2019
 

Foxtons Group plc

("Foxtons" or the "Company")

Directorate Change

The Board is pleased to announce the appointment of Alan Giles as a non-executive Director of the Company with effect from 1 June 2019. Alan will be a member of the Remuneration, Audit and Nomination Committees.

Mr Giles has extensive experience as a non-executive director and is currently the senior independent non-executive director of Perpetual Income and Growth Investment Trust plc. He is also the Chairman of The Remuneration Consultants Group, an associate fellow of Saïd Business School, University of Oxford, and an honorary visiting professor at Cass Business School, City, University of London.

Mr Giles was the senior independent non-executive director and chairman of the remuneration committee of Rentokil Initial plc until May 2017, and the senior independent non-executive board member and remuneration committee chairman of The Competition and Markets Authority until March 2019. He was formerly chairman of Fat Face Group Limited, chief executive of HMV Group Plc, managing director of Waterstones, and an executive director of WH Smith Plc, and he previously held non-executive directorships at The Office of Fair Trading, Somerfield Plc and Wilson Bowden Plc.

Garry Watts, Chairman of Foxtons, said:

"Alan has a distinguished and highly relevant background. His experience and skills will be a significant addition to Foxtons. I and my colleagues greatly look forward to working with him."

Alan Giles said:

"I am delighted to be joining Foxtons, which is a well differentiated brand with a strong market position. I am looking forward to working with the Board and management team."

 

There are no other details or disclosures required under LR 9.6.13R of the Financial Conduct Authority's Listing Rules.

 

20 May 2019

 

For further information please contact:

Foxtons Group plc

Nic Budden, Chief Executive Officer

Mark Berry, Chief Financial Officer

Muhammed Patel, Investor Relations

+44 20 7893 6261

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAQDLFFKEFBBBZ
Date   Source Headline
1st Jun 202612:44 pmRNSTotal Voting Rights
26th May 20269:23 amRNSDirectorate change
22nd May 20265:10 pmRNSDirector/PDMR Shareholding
7th May 20264:27 pmRNSResult of AGM
1st May 202612:04 pmRNSTotal Voting Rights
23rd Apr 20267:00 amRNSQ1 2026 Trading Update
13th Apr 20265:05 pmRNSTransaction in Own Shares
10th Apr 20266:15 pmRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20263:44 pmRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSDirector/PDMR Shareholding
1st Apr 202611:33 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSNotice of AGM and Annual Report and Accounts
31st Mar 20261:46 pmRNSTransaction in Own Shares
30th Mar 20265:19 pmRNSTransaction in Own Shares
27th Mar 20265:26 pmRNSTransaction in Own Shares
26th Mar 20265:43 pmRNSTransaction in Own Shares
25th Mar 20269:23 amRNSTransaction in Own Shares
20th Mar 20264:44 pmRNSTransaction in Own Shares
20th Mar 202611:08 amRNSHolding(s) in Company
19th Mar 20263:38 pmRNSTransaction in Own Shares
18th Mar 20263:26 pmRNSTransaction in Own Shares
17th Mar 20265:37 pmRNSTransaction in Own Shares
16th Mar 20266:12 pmRNSTransaction in Own Shares
13th Mar 20265:14 pmRNSTransaction in Own Shares
12th Mar 20265:54 pmRNSTransaction in Own Shares
11th Mar 20265:33 pmRNSTransaction in Own Shares
10th Mar 20263:07 pmRNSTransaction in Own Shares
10th Mar 20263:07 pmRNSTransaction in Own Shares
6th Mar 20265:55 pmRNSTransaction in Own Shares
6th Mar 20264:12 pmRNSDirector/PDMR Shareholding
5th Mar 20265:48 pmRNSTransaction in Own Shares
5th Mar 20267:00 amRNSFull Year Results For Year Ended 31 December 2025
20th Feb 202611:32 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSBoard Change
2nd Feb 20262:22 pmRNSTotal Voting Rights
27th Jan 20266:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSAcquisition of Birmingham-based FleetMilne
15th Jan 20267:00 amRNSUnaudited Year End Trading Update and Acquisition
14th Jan 20265:28 pmRNSTransaction in Own Shares
13th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
8th Jan 20263:04 pmRNSHolding(s) in Company
2nd Jan 202611:59 amRNSTotal Voting Rights
22nd Dec 20255:40 pmRNSTransaction in Own Shares
22nd Dec 20255:40 pmRNSTransaction in Own Shares
17th Dec 20255:24 pmRNSTransaction in Own Shares
2nd Dec 20255:49 pmRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
1st Dec 202510:38 amRNSTotal Voting Rights
26th Nov 20256:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.